Linking Breast Cancer Patients With Alternative Therapies

Biological-based therapies such as diet supplements and vitamins are the most popular complementary and alternative medicines for women recovering from breast cancer, according to a Michigan State University researcher working to create a support intervention for women in treatment for the disease.

Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin Extended-release/simvastatin)

Abbott has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR®, a cholesterol medication. SIMCOR is a fixed-dose combination of niacin extended-release and simvastatin.

Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin Extended-release/simvastatin)

Abbott (NYSE: ABT) has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR®, a cholesterol medication. SIMCOR is a fixed-dose combination of niacin extended-release and simvastatin.

Arizona State Answers Call For Information, Debuts Shot Finder

As 2009 H1N1 influenza continues to spread, the Arizona Department of Health Services (ADHS) has answered the need for actionable health information through partnerships with Google and county health departments.

H1N1 Health Alert: Children With Asthma At Greater Risk From H1N1 Influenza

Children with asthma are at greater risk to develop serious symptoms from H1N1 (swine) flu than from seasonal flu, according to a new study. According to the Centers for Disease Control and Prevention (CDC) a new Canadian study found that children hospitalized with H1N1 were more likely to have asthma (22%) compared to children hospitalized [...]